Aridanin Attenuates Behavior Deficits and Neuroinflammatory Response in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s Disease in Mice

ABSTRACT

Background: Parkinson’s disease (PD), the second most prevalent neurological illness, is treated with pharmacologic and nonpharmacologic techniques, including medicinal plants and their extracts. Purpose: We assessed the anti-neurodegenerative properties of aridanin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced PD in mice. Materials and Methods: In the current investigation, the neuroprotective potential of aridanin in the MPTP-induced PD animal model via behavioral analysis, oxidative stress, pro-inflammatory cytokines, and histopathology was determined. Results: The results showed that mice treated with MPTP had mobility, motor issues, and behavioral dysfunctions. When mice were challenged with MPTP, they had low antioxidant levels. The levels of malondialdehyde (MDA) and pro-inflammatory cytokines were high in MPTP-treated mice. There are signs of PD based on these results. Behavioral effects were improved, antioxidant levels increased, and MDA and proinflammatory cytokines levels decreased in animals treated with aridanin. Conclusion: Thus, in combination, aridanin therapy guards against MPTP-induced neuronal loss, neuroinflammation, oxidative stress, and motor dysfunction in PD mice.

KEYWORDS

• Parkinson’s disease
• aridanin
• 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine hydrochloride
• antioxidants

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241251916Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 20, ISSUE 4Fraxinus excelsior L. for Prevention of Capecitabine-induced Enterocolitis in Rat: An Integrated Biochemical, Molecular, and Histopathological StudyLi Li, HaiYan Tan, TianLu Su · pp. 1086–1099Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Lijing-Anfei Decoction Attenuates COPD in a Mouse Model: Network Pharmacology Analysis, Molecular Docking, and Experimental ValidationJiajia Zhu, Jie Liu, Wei Jia, Guoqiang Shao, Haizhu Xu · pp. 1100–1113Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Anticancer Effects of Vaccinium arctostaphylos L. through HOTAIR/miR-124/Notch1 Axis of Hepatocellular Carcinoma in Rat: A Biochemical, Molecular, Immunohistochemical, and Histopathological ApproachesChengchen Zhou, Xiaoling Qin, Jingyi Wang, Yongchang Liu · pp. 1114–1127Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Eriocitrin in the Treatment of Diabetic Nephropathy: Amelioration Against Oxidative Burst and Inflammation ApproachHui Deng, Yarong Li, Shulan Han, Min Lan, Liqin Cui, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Zhong Li · pp. 1128–1140Original Research ArticleSame type: Article